针对心肌病的量身定制治疗方法
Athanasios Bakalakos1, Emanuele Monda1,2, Perry Mark Elliott3
1Institute of Cardiovascular Science, University College London, London, UK.
Nature reviews. Cardiology
|June 27, 2025
概括
心肌病是一种复杂的心肌疾病,传统上专注于症状管理. 新兴疗法旨在针对根源的遗传原因,为患有这些进展性心脏病的患者提供新的希望.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 心肌病包括各种各样的心肌疾病,其原因和机制各异.
- 目前的治疗主要针对症状,并预防诸如心力衰竭等并发症,治疗渐进性功能障碍的成功有限.
- 心脏病学中几乎没有针对病因的治疗方法,这使得心肌病成为治疗创新的首要领域.
研究的目的:
- 审查对心肌病有前途的治疗方法.
- 讨论针对心肌疾病的潜在原因的新策略.
- 探索这些创新疗法对患者及其家人的潜在影响.
主要方法:
- 关于心肌病病原和治疗的当前文献的综述.
- 对新兴药物和基因疗法的分析.
- 讨论涉及疾病进展的细胞和分子途径.
主要成果:
- 确定了一些对心肌病有前途的治疗策略.
- 突出治疗方法的潜力,通过针对遗传原因来解决疾病的源头.
- 探索新的或重新使用的药理学剂和遗传变异修饰.
结论:
- 心肌病为开发向治疗提供了一个独特的机会,因为它们的起源往往是单一的.
- 了解分子通路的进步为创新治疗铺平了道路.
- 新的治疗方法有望显著改善患者的治疗结果和生活质量.
相关概念视频
Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743
Cardiomyopathy III: Hypertrophic Cardiomyopathy
64
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
Myocarditis III: Medical Management
18
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
18
Cardiomyopathy IV: Restrictive Cardiomyopathy
42
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
42


